S. 724 extends the temporary federal scheduling order for fentanyl-related substances by six months, pushing the deadline from March 31, 2025 to September 30, 2025. The bill amends an existing law that allows the government to quickly classify new fentanyl analogues (chemically similar drugs) as controlled substances without the lengthy standard regulatory process. This affects drug manufacturers, law enforcement, and anyone involved in the fentanyl supply chain by continuing restrictions on these substances. The bill does not include new funding and simply delays the expiration of current emergency scheduling authority, giving Congress more time to decide on a permanent solution for controlling synthetic fentanyl-related drugs.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.